• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康受试者单次及多次静脉输注氧氟沙星后的药代动力学。 (注:原英文表述“Pharmacokinetics of ofloxacin after single and multiple intravenous infusions in healthy subjects.”中多了一个“of”,正确表述应为“Pharmacokinetics of ofloxacin after single and multiple intravenous infusions in healthy subjects” )

Pharmacokinetics of ofloxacin after single and multiple intravenous infusions in healthy subjects.

作者信息

Farinotti R, Trouvin J H, Bocquet V, Vermerie N, Carbon C

机构信息

Department of Pharmacy, Hôpital Bichat, Paris, France.

出版信息

Antimicrob Agents Chemother. 1988 Oct;32(10):1590-2. doi: 10.1128/AAC.32.10.1590.

DOI:10.1128/AAC.32.10.1590
PMID:3190187
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC175926/
Abstract

The pharmacokinetics of ofloxacin were investigated in eight healthy male volunteers. A single infusion (200 mg over 0.5 h) was performed on day 1, followed by a washout period of 2 weeks. Repeated administrations were performed for 4 days (200 mg every 12 h). Pharmacokinetic parameters were determined from the plasma decay curves of the single and the last of the multiple administrations. Ofloxacin kinetics after the single dose were best described by a two-phase curve with a total body clearance of 241.6 +/- 43.3 ml min-1, a volume of distribution of 112 +/- 23.1 liters, and an elimination half-life of 5.4 +/- 0.8 h. The extrapolated area under the curve (AUC0-infinity) was 14 +/- 2.3 mg.h liter-1. The pharmacokinetics were not significantly modified by repeated administration, demonstrated mainly by the AUC0-12 value of the last infusion (13.4 +/- 2.2 mg.h liter-1). We conclude that, with intravenous multiple doses every 12 h, the steady state is reached within 24 to 36 h and no abnormal accumulation or changes in pharmacokinetic parameters occur.

摘要

在8名健康男性志愿者中研究了氧氟沙星的药代动力学。第1天进行单次输注(0.5小时内输注200毫克),随后有2周的洗脱期。重复给药4天(每12小时200毫克)。根据单次给药和多次给药最后一次给药后的血浆衰减曲线确定药代动力学参数。单次给药后氧氟沙星的动力学最好用双相曲线描述,全身清除率为241.6±43.3毫升·分钟-1,分布容积为112±23.1升,消除半衰期为5.4±0.8小时。曲线下面积外推值(AUC0-∞)为14±2.3毫克·小时·升-1。多次给药未显著改变药代动力学,主要由最后一次输注的AUC0-12值(13.4±2.2毫克·小时·升-1)证明。我们得出结论,每12小时静脉注射多次剂量,在24至36小时内达到稳态,药代动力学参数无异常蓄积或变化。

相似文献

1
Pharmacokinetics of ofloxacin after single and multiple intravenous infusions in healthy subjects.健康受试者单次及多次静脉输注氧氟沙星后的药代动力学。 (注:原英文表述“Pharmacokinetics of ofloxacin after single and multiple intravenous infusions in healthy subjects.”中多了一个“of”,正确表述应为“Pharmacokinetics of ofloxacin after single and multiple intravenous infusions in healthy subjects” )
Antimicrob Agents Chemother. 1988 Oct;32(10):1590-2. doi: 10.1128/AAC.32.10.1590.
2
Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers.健康志愿者中多次口服每日一次750毫克和1克剂量左氧氟沙星的安全性和药代动力学的双盲评估。
Antimicrob Agents Chemother. 1998 Apr;42(4):885-8. doi: 10.1128/AAC.42.4.885.
3
Kinetics of ofloxacin and its metabolites in cerebrospinal fluid after a single intravenous infusion of 400 milligrams of ofloxacin.单次静脉输注400毫克氧氟沙星后脑脊液中氧氟沙星及其代谢物的动力学
Antimicrob Agents Chemother. 1994 Aug;38(8):1849-53. doi: 10.1128/AAC.38.8.1849.
4
Safety and pharmacokinetics of multiple doses of intravenous ofloxacin in healthy volunteers.健康志愿者多次静脉注射氧氟沙星的安全性和药代动力学
Antimicrob Agents Chemother. 1992 Feb;36(2):308-12. doi: 10.1128/AAC.36.2.308.
5
Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever.耐多药伤寒患儿口服及静脉注射氧氟沙星的药代动力学
Antimicrob Agents Chemother. 1996 Sep;40(9):2167-72. doi: 10.1128/AAC.40.9.2167.
6
Comparative pharmacokinetics of intravenous ofloxacin and ciprofloxacin.氧氟沙星和环丙沙星静脉注射的比较药代动力学。
J Antimicrob Chemother. 1988 Sep;22 Suppl C:73-9. doi: 10.1093/jac/22.supplement_c.73.
7
Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine.口服左氧氟沙星在接受齐多夫定治疗的人类免疫缺陷病毒感染个体中的药代动力学和安全性。
Antimicrob Agents Chemother. 1997 Aug;41(8):1765-9. doi: 10.1128/AAC.41.8.1765.
8
Pharmacokinetics of ofloxacin in broiler chicken.氧氟沙星在肉鸡体内的药代动力学
J Vet Pharmacol Ther. 2006 Jun;29(3):185-9. doi: 10.1111/j.1365-2885.2006.00729.x.
9
Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects.头孢吡肟在健康受试者单次及多次静脉给药后的药代动力学。
Antimicrob Agents Chemother. 1992 Mar;36(3):552-7. doi: 10.1128/AAC.36.3.552.
10
Pharmacokinetics and safety of levofloxacin in patients with human immunodeficiency virus infection.左氧氟沙星在人类免疫缺陷病毒感染患者中的药代动力学及安全性
Antimicrob Agents Chemother. 1994 Apr;38(4):799-804. doi: 10.1128/AAC.38.4.799.

引用本文的文献

1
Pharmacokinetics of Intravenous Finafloxacin in Healthy Volunteers.健康志愿者体内法莫替丁的药代动力学。
Antimicrob Agents Chemother. 2017 Sep 22;61(10). doi: 10.1128/AAC.01122-17. Print 2017 Oct.
2
Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever.耐多药伤寒患儿口服及静脉注射氧氟沙星的药代动力学
Antimicrob Agents Chemother. 1996 Sep;40(9):2167-72. doi: 10.1128/AAC.40.9.2167.
3
Treatment of experimental endocarditis due to ampicillin-susceptible or ampicillin-resistant Salmonella enteritidis.对由氨苄西林敏感或耐药的肠炎沙门氏菌引起的实验性心内膜炎的治疗。
Antimicrob Agents Chemother. 1996 Jul;40(7):1589-93. doi: 10.1128/AAC.40.7.1589.
4
Pharmacokinetics and serum bactericidal activities of quinolones in combination with clindamycin, metronidazole, and ornidazole.喹诺酮类药物与克林霉素、甲硝唑和奥硝唑联合应用的药代动力学及血清杀菌活性
Antimicrob Agents Chemother. 1990 Dec;34(12):2407-14. doi: 10.1128/AAC.34.12.2407.
5
Bioavailability and pharmacokinetics of ofloxacin in healthy volunteers.氧氟沙星在健康志愿者中的生物利用度和药代动力学。 需要说明的是,原英文文本中“of ofloxacin”表述有误,多了一个“of” 。
Antimicrob Agents Chemother. 1991 Feb;35(2):384-6. doi: 10.1128/AAC.35.2.384.
6
Ofloxacin pharmacokinetics in mechanically ventilated patients.机械通气患者中氧氟沙星的药代动力学
Antimicrob Agents Chemother. 1991 Aug;35(8):1582-5. doi: 10.1128/AAC.35.8.1582.
7
High-pressure liquid chromatography and microbiological assay of serum ofloxacin levels in adults receiving intravenous and oral therapy for skin infections.接受皮肤感染静脉及口服治疗的成人血清氧氟沙星水平的高压液相色谱法及微生物学测定
Antimicrob Agents Chemother. 1991 Dec;35(12):2558-61. doi: 10.1128/AAC.35.12.2558.
8
Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.氧氟沙星。对其抗菌活性、药理学及治疗用途的重新评估。
Drugs. 1991 Nov;42(5):825-76. doi: 10.2165/00003495-199142050-00008.
9
Ofloxacin clinical pharmacokinetics.氧氟沙星的临床药代动力学。
Clin Pharmacokinet. 1992 Jan;22(1):32-46. doi: 10.2165/00003088-199222010-00004.

本文引用的文献

1
Pharmacokinetics of ofloxacin after parenteral and oral administration.氧氟沙星经肠胃外和口服给药后的药代动力学。 (原文中“Pharmacokinetics of ofloxacin after parenteral and oral administration.” 多了一个of,正确的应该是“Pharmacokinetics of ofloxacin after parenteral and oral administration.” 翻译后的句子根据正确的原文进行了修正)
Antimicrob Agents Chemother. 1987 Sep;31(9):1338-42. doi: 10.1128/AAC.31.9.1338.
2
Ofloxacin pharmacokinetics in renal failure.氧氟沙星在肾衰竭患者中的药代动力学。
Antimicrob Agents Chemother. 1987 Feb;31(2):156-60. doi: 10.1128/AAC.31.2.156.
3
Multiple-dose pharmacokinetics of ofloxacin, a new broad-spectrum antimicrobial agent.新型广谱抗菌剂氧氟沙星的多剂量药代动力学
Clin Ther. 1986;8(6):632-45.
4
Ofloxacin: serum and skin blister fluid pharmacokinetics in the fasting and non-fasting state.氧氟沙星:禁食和非禁食状态下的血清及皮肤水疱液药代动力学
J Antimicrob Chemother. 1986 Jun;17(6):795-800. doi: 10.1093/jac/17.6.795.
5
The effect of food on the pharmacokinetics of ofloxacin.食物对氧氟沙星药代动力学的影响。 (注:原文中“of ofloxacin”多了一个“of”)
Curr Med Res Opin. 1986;10(3):166-71. doi: 10.1185/03007998609110436.
6
Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.氧氟沙星。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1987 Apr;33(4):346-91. doi: 10.2165/00003495-198733040-00003.